Generics - Asia-Pacific, Patents

Filter

Current filters:

Asia-PacificPatents

Popular Filters

1 to 25 of 43 results

Indian drugmakers readying for next “Patent cliff”

24-02-2014

The strategic drug reviews, as well as mergers and acquisitions – such as Actavis buying out Forest…

Asia-PacificGenericsIndiaMergers & AcquisitionsPatentsPharmaceuticalRegulation

Nissan Chemical and Kowa to sue generic drugmakers over Livalo patent infringements

30-12-2013

With the commencement this year of manufacturing and selling generic copies of the hypercholesterolemia…

Asia-PacificCardio-vascularGenericsKowaLegalLivaloNissan ChemicalPatents

Australian government urged to hold the line on IP protection

Australian government urged to hold the line on IP protection

11-12-2013

The Generic Medicines Industry of Australia (GMiA) is renewing its call on the Australian government…

Asia-PacificAustraliaGenericsPatents

No changes in Australian domestic IP warranted, say generic drugmakers

No changes in Australian domestic IP warranted, say generic drugmakers

26-11-2013

Members of the generic drugs industry are calling on the Australian government to support efforts to…

Asia-PacificGenericsNorth AmericaPatentsPolitics

Two more drug patents revoked in India

12-08-2013

In another blow for intellectual property in India, local drugmaker Ajanta Pharma has prevailed in revoking…

Ajanta PharmaAllerganAsia-PacificCombiganGanfortGenericsOphthalmicsPatentsPharmaceutical

Indian citizens lack free access to essential generic medicines, while policies risk undermining new drug research funding

17-07-2013

Modern India has the third largest national economy in the world in purchasing power adjusted terms.…

Asia-PacificFinancialGenericsHealthcarePatentsResearch

Medecins Sans Frontieres wants the Trans-Pacific Partnership to amend terms

16-07-2013

Worldwide humanitarian organization Medecins Sans Frontieres (MSF) is urging the countries participating…

Asia-PacificGenericsPatentsPharmaceuticalPricing

Intas Pharma settles with Roche over Xeloda; Merck & Co wins injunction against Aprica

25-06-2013

Indian drugmaker Intas Pharmaceuticals and its wholly owned subsidiary Accord Healthcare have entered…

Aprica PharmaceuticalsAsia-PacificDiabetesGenericsIntas PharmaceuticalsMerck & CoNorth AmericaOncologyPatentsRocheXeloda

Government health care reforms foster development China's Pharma market, says F&S

28-05-2013

Rising incomes, improving health care infrastructure and enhanced insurance systems have propelled the…

Asia-PacificGenericsHealthcareMarkets & MarketingPatentsPharmaceuticalPolitics

Activists protest in front of the European Parliament to stop EU-India trade deal "harmful" provisions

09-04-2013

As European Commission pressure mounts on India to rush into signing a free trade agreement (FTA) by…

Asia-PacificEuropeGenericsPatentsPharmaceuticalPoliticsPricing

US-India Business Council has concerns over India's ruling on Novartis' Glivec

03-04-2013

This week's long awaited Supreme Court of India ruling, which denied a patent on Swiss drug major Novartis'…

Asia-PacificGenericsGlivecNovartisPatentsPharmaceutical

India's Supreme Court denies Novartis Glivec patent appeal

02-04-2013

In a landmark decision issued on Monday (April 1) by the Indian Supreme Court has denied Swiss drug major…

Asia-PacificGenericsGlivecLegalNovartisOncologyPatentsPharmaceutical

DNP+ and MSF urge India to reject EU demands on trade deal before April deadline

13-03-2013

Pressure is mounting on India to quickly sign off on a free trade agreement with the European Union which…

Asia-PacificEuropeGenericsPatentsPharmaceuticalPolitics

Thailand flouts pharmaceutical patent protection; report

08-03-2013

Lax enforcement of patent regulations in Thailand is alienating American intellectual property laws,…

Asia-PacificGenericsMarkets & MarketingPatentsPharmaceutical

Further savings expected following Australian Crestor patent decision, says GMiA

07-03-2013

In a decision brought down by the Australian Federal Court earlier this week, suppliers of generic medicines…

Asia-PacificAstraZenecaCardio-vascularCrestorGenericsPatentsPharmaceuticalPricing

Indian patent appeal board upholds compulsory license on Bayer's Nexavar

05-03-2013

After much delay, the verdict into German pharmaceutical major Bayer's (BAYN: DE) appeal against the…

Asia-PacificBayerGenericsNatco PharmaNexavarOncologyPatentsPharmaceutical

Cipla prevails in Sutent patent dispute with Pfizer; puts hold on Cipla Medpro deal

12-02-2013

The Indian patent office has again ruled in favor of domestic drugmaker Cipla (BSE: 500087), reinstating…

Asia-PacificCiplaCipla MedproGenericsLegalMergers & AcquisitionsOncologyPatentsPfizerRest of the WorldSutent

Indian govt plans compulsory licences for trastuzumab, ixabepilone and dasatinib

15-01-2013

The Indian government's move to issue compulsory licences to three more patented cancer drugs has left…

Asia-PacificAvastinBristol-Myers SquibbGenericsIxempraOncologyPatentsPharmaceuticalRocheSprycel

MSF update on Novartis versus India, Supreme Court case

18-11-2012

Humanitarian health organization Medecins Sans Frontieres (MSF) says it continues to follow progress…

Asia-PacificGenericsGlivecLegalNovartisOncologyPatentsPharmaceutical

India's Cipla cuts prices of three cancer drugs

12-11-2012

Following what Indian drugmaker Cipla (BSE: 500087) said was an "overwhelming response" on the price…

Asia-PacificcapecitabineCipladocetaxelerlotinibGenericsOncologyPatentsPfizerPharmaceuticalPricingSunitinib MalateSutent

1 to 25 of 43 results

Back to top